Gut microbiota, inflammatory bowel disease and colorectal cancer
Ana Elisa Valencise Quaglio, Thaís Gagno Grillo, Ellen Cristina Souza de Oliveira, Luiz Claudio Di Stasi, Lígia Yukie Sassaki
Abstract
, and ETBF. Future research can evaluate the advantages of modulating the gut microbiota as preventive measures in CRC high-risk patients, directly affecting the prognosis of the disease and the quality of life of patients.
Topics & Concepts
DysbiosisInflammatory bowel diseaseBacteroides fragilisGut floraUlcerative colitisColorectal cancerMicrobiomeIrritable bowel syndromeBacteroidesImmunologyFusobacteriumMedicineColitisDiseaseCancerBiologyGastroenterologyMicrobiologyInternal medicineBioinformaticsBacteriaAntibioticsGeneticsGut microbiota and healthClostridium difficile and Clostridium perfringens researchInflammatory Bowel Disease